Skip to main content

05.08.2023 | Special Feature: Review Article

Contrast-enhanced endoscopic ultrasound for swollen lymph nodes

verfasst von: Tanyaporn Chantarojanasiri, Thawee Ratanachu-ek, Eizaburo Ohno, Yoshiki Hirooka

Erschienen in: Journal of Medical Ultrasonics

Einloggen, um Zugang zu erhalten

Abstract

Endoscopic ultrasound (EUS) is an important tool for the evaluation of lymphadenopathy, especially in intra-thoracic or intra-abdominal regions. EUS also provides tissue diagnosis via EUS fine-needle aspiration or biopsy. To select the target for biopsy or aspiration, conventional B-mode images are used for the evaluation, but this approach still lacks diagnostic accuracy. Contrast-enhanced EUS has been used to evaluate the vascularity of lesions. Most malignant lymphadenopathy shows heterogenous enhancement or defect of enhancement, while quantitative studies using time-intensity curves in contrast-enhanced harmonic EUS show a rapid decline in enhancement pattern. These findings are useful as an auxiliary method for tissue diagnosis or in cases in which tissue diagnosis is contraindicated.
Literatur
1.
Zurück zum Zitat Mao Y, Hedgire S, Harisinghani M. Radiologic assessment of lymph nodes in oncologic patients. Curr Radiol Rep. 2013;2:36.CrossRef Mao Y, Hedgire S, Harisinghani M. Radiologic assessment of lymph nodes in oncologic patients. Curr Radiol Rep. 2013;2:36.CrossRef
2.
Zurück zum Zitat Gao Y, Li J, Ma X, et al. The value of four imaging modalities in diagnosing lymph node involvement in rectal cancer: an overview and adjusted indirect comparison. Clin Exp Med. 2019;19:225–34.CrossRefPubMed Gao Y, Li J, Ma X, et al. The value of four imaging modalities in diagnosing lymph node involvement in rectal cancer: an overview and adjusted indirect comparison. Clin Exp Med. 2019;19:225–34.CrossRefPubMed
3.
Zurück zum Zitat Takasaki Y, Irisawa A, Shibukawa G, et al. New endoscopic ultrasonography criteria for malignant lymphadenopathy based on inter-rater agreement. PLoS One. 2019;14: e0212427.CrossRefPubMedPubMedCentral Takasaki Y, Irisawa A, Shibukawa G, et al. New endoscopic ultrasonography criteria for malignant lymphadenopathy based on inter-rater agreement. PLoS One. 2019;14: e0212427.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–6.CrossRefPubMed Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–6.CrossRefPubMed
5.
Zurück zum Zitat Vassallo P, Edel G, Roos N, et al. In-vitro high-resolution ultrasonography of benign and malignant lymph nodes. A sonographic-pathologic correlation. Investig Radiol. 1993;28:698–705.CrossRef Vassallo P, Edel G, Roos N, et al. In-vitro high-resolution ultrasonography of benign and malignant lymph nodes. A sonographic-pathologic correlation. Investig Radiol. 1993;28:698–705.CrossRef
6.
Zurück zum Zitat Yoshida K, Iwashita T, Uemura S, et al. Efficacy of contrast-enhanced EUS for lymphadenopathy: a prospective multicenter pilot study (with videos). Gastrointest Endosc. 2019;90:242–50.CrossRefPubMed Yoshida K, Iwashita T, Uemura S, et al. Efficacy of contrast-enhanced EUS for lymphadenopathy: a prospective multicenter pilot study (with videos). Gastrointest Endosc. 2019;90:242–50.CrossRefPubMed
7.
Zurück zum Zitat Bansal RK, Choudhary NS, Patle SK, et al. Diagnostic adequacy and safety of endoscopic ultrasound-guided fine-needle aspiration in patients with lymphadenopathy in a large cohort. Endosc Int Open. 2018;6:E421–4.CrossRefPubMedPubMedCentral Bansal RK, Choudhary NS, Patle SK, et al. Diagnostic adequacy and safety of endoscopic ultrasound-guided fine-needle aspiration in patients with lymphadenopathy in a large cohort. Endosc Int Open. 2018;6:E421–4.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chen L, Li Y, Gao X, et al. High diagnostic accuracy and safety of endoscopic ultrasound-guided fine-needle aspiration in malignant lymph nodes: a systematic review and meta-analysis. Dig Dis Sci. 2021;66:2763–75.CrossRefPubMed Chen L, Li Y, Gao X, et al. High diagnostic accuracy and safety of endoscopic ultrasound-guided fine-needle aspiration in malignant lymph nodes: a systematic review and meta-analysis. Dig Dis Sci. 2021;66:2763–75.CrossRefPubMed
9.
Zurück zum Zitat Redondo-Cerezo E, Martinez-Cara JG, Jimenez-Rosales R, et al. Endoscopic ultrasound in gastric cancer staging before and after neoadjuvant chemotherapy. A comparison with PET-CT in a clinical series. United Eur Gastroenterol J. 2017;5:641–7.CrossRef Redondo-Cerezo E, Martinez-Cara JG, Jimenez-Rosales R, et al. Endoscopic ultrasound in gastric cancer staging before and after neoadjuvant chemotherapy. A comparison with PET-CT in a clinical series. United Eur Gastroenterol J. 2017;5:641–7.CrossRef
10.
Zurück zum Zitat Hulshoff JB, Mul VEM, de Boer HEM, et al. Impact of endoscopic ultrasonography on (18)F-FDG-PET/CT upfront towards patient specific esophageal cancer treatment. Ann Surg Oncol. 2017;24:1828–34.CrossRefPubMedPubMedCentral Hulshoff JB, Mul VEM, de Boer HEM, et al. Impact of endoscopic ultrasonography on (18)F-FDG-PET/CT upfront towards patient specific esophageal cancer treatment. Ann Surg Oncol. 2017;24:1828–34.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Tschammler A, Ott G, Schang T, et al. Lymphadenopathy: differentiation of benign from malignant disease-color Doppler US assessment of intranodal angioarchitecture. Radiology. 1998;208:117–23.CrossRefPubMed Tschammler A, Ott G, Schang T, et al. Lymphadenopathy: differentiation of benign from malignant disease-color Doppler US assessment of intranodal angioarchitecture. Radiology. 1998;208:117–23.CrossRefPubMed
13.
Zurück zum Zitat Giovannini M, Thomas B, Erwan B, et al. Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. World J Gastroenterol. 2009;15:1587–93.CrossRefPubMedPubMedCentral Giovannini M, Thomas B, Erwan B, et al. Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. World J Gastroenterol. 2009;15:1587–93.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Miyata T, Kitano M, Omoto S, et al. Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma. World J Gastroenterol. 2016;22:3381–91.CrossRefPubMedPubMedCentral Miyata T, Kitano M, Omoto S, et al. Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma. World J Gastroenterol. 2016;22:3381–91.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Matsuda Y, Yabuuchi I. Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology. 1986;161:701–5.CrossRefPubMed Matsuda Y, Yabuuchi I. Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology. 1986;161:701–5.CrossRefPubMed
16.
Zurück zum Zitat Hirooka Y, Naitoh Y, Goto H, et al. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc. 1997;46:166–9.CrossRefPubMed Hirooka Y, Naitoh Y, Goto H, et al. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc. 1997;46:166–9.CrossRefPubMed
17.
Zurück zum Zitat Kitano M, Sakamoto H, Kudo M. Contrast-enhanced endoscopic ultrasound. Dig Endosc. 2014;26(Suppl 1):79–85.CrossRefPubMed Kitano M, Sakamoto H, Kudo M. Contrast-enhanced endoscopic ultrasound. Dig Endosc. 2014;26(Suppl 1):79–85.CrossRefPubMed
18.
Zurück zum Zitat Hirooka Y, Itoh A, Kawashima H, et al. Contrast-enhanced endoscopic ultrasonography in digestive diseases. J Gastroenterol. 2012;47:1063–72.CrossRefPubMed Hirooka Y, Itoh A, Kawashima H, et al. Contrast-enhanced endoscopic ultrasonography in digestive diseases. J Gastroenterol. 2012;47:1063–72.CrossRefPubMed
19.
Zurück zum Zitat Ohno E, Kawashima H, Hashimoto S, et al. Current status of tissue harmonic imaging in endoscopic ultrasonography (EUS) and EUS-elastography in pancreatobiliary diseases. Dig Endosc. 2015;27(Suppl 1):68–73.CrossRefPubMed Ohno E, Kawashima H, Hashimoto S, et al. Current status of tissue harmonic imaging in endoscopic ultrasonography (EUS) and EUS-elastography in pancreatobiliary diseases. Dig Endosc. 2015;27(Suppl 1):68–73.CrossRefPubMed
20.
Zurück zum Zitat Desser TS, Jeffrey RB. Tissue harmonic imaging techniques: physical principles and clinical applications. Semin Ultrasound CT MR. 2001;22:1–10.CrossRefPubMed Desser TS, Jeffrey RB. Tissue harmonic imaging techniques: physical principles and clinical applications. Semin Ultrasound CT MR. 2001;22:1–10.CrossRefPubMed
21.
Zurück zum Zitat Imazu H, Kanazawa K, Mori N, et al. Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma. Scand J Gastroenterol. 2012;47:853–60.CrossRefPubMed Imazu H, Kanazawa K, Mori N, et al. Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma. Scand J Gastroenterol. 2012;47:853–60.CrossRefPubMed
22.
Zurück zum Zitat Matsubara H, Itoh A, Kawashima H, et al. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases. Pancreas. 2011;40:1073–9.CrossRefPubMed Matsubara H, Itoh A, Kawashima H, et al. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases. Pancreas. 2011;40:1073–9.CrossRefPubMed
23.
Zurück zum Zitat Hocke M, Menges M, Topalidis T, et al. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol. 2008;134:473–80.CrossRefPubMed Hocke M, Menges M, Topalidis T, et al. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol. 2008;134:473–80.CrossRefPubMed
24.
Zurück zum Zitat Chantarojanasiri T, Hirooka Y, Kawashima H, et al. Endoscopic ultrasound in diagnosis of solid pancreatic lesions: Elastography or contrast-enhanced harmonic alone versus the combination. Endosc Int Open. 2017;5:E1136–43.CrossRefPubMedPubMedCentral Chantarojanasiri T, Hirooka Y, Kawashima H, et al. Endoscopic ultrasound in diagnosis of solid pancreatic lesions: Elastography or contrast-enhanced harmonic alone versus the combination. Endosc Int Open. 2017;5:E1136–43.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kojima S, Goto H, Hirooka Y, et al. Differentiation of benign and malignant lymph nodes with contrast-enhanced echolymphography using endoscopic ultrasound-guided puncture. Hepatogastroenterology. 2003;50:1285–91.PubMed Kojima S, Goto H, Hirooka Y, et al. Differentiation of benign and malignant lymph nodes with contrast-enhanced echolymphography using endoscopic ultrasound-guided puncture. Hepatogastroenterology. 2003;50:1285–91.PubMed
26.
Zurück zum Zitat Xia Y, Kitano M, Kudo M, et al. Characterization of intra-abdominal lesions of undetermined origin by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc. 2010;72:637–42.CrossRefPubMed Xia Y, Kitano M, Kudo M, et al. Characterization of intra-abdominal lesions of undetermined origin by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc. 2010;72:637–42.CrossRefPubMed
27.
Zurück zum Zitat Kanamori A, Hirooka Y, Itoh A, et al. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol. 2006;101:45–51.CrossRefPubMed Kanamori A, Hirooka Y, Itoh A, et al. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol. 2006;101:45–51.CrossRefPubMed
28.
Zurück zum Zitat Lisotti A, Ricci C, Serrani M, et al. Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis. Endosc Int Open. 2019;7:E504–13.CrossRefPubMedPubMedCentral Lisotti A, Ricci C, Serrani M, et al. Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis. Endosc Int Open. 2019;7:E504–13.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yoshida K, Iwashita T, Mita N, et al. Efficacy of contrast-enhanced endoscopic ultrasonography for the differentiation of non-Hodgkin’s lymphoma: a single-center retrospective cohort study. J Clin Med. 2023;12:2054.CrossRefPubMedPubMedCentral Yoshida K, Iwashita T, Mita N, et al. Efficacy of contrast-enhanced endoscopic ultrasonography for the differentiation of non-Hodgkin’s lymphoma: a single-center retrospective cohort study. J Clin Med. 2023;12:2054.CrossRefPubMedPubMedCentral
Metadaten
Titel
Contrast-enhanced endoscopic ultrasound for swollen lymph nodes
verfasst von
Tanyaporn Chantarojanasiri
Thawee Ratanachu-ek
Eizaburo Ohno
Yoshiki Hirooka
Publikationsdatum
05.08.2023
Verlag
Springer Nature Singapore
Erschienen in
Journal of Medical Ultrasonics
Print ISSN: 1346-4523
Elektronische ISSN: 1613-2254
DOI
https://doi.org/10.1007/s10396-023-01347-2

Neu im Fachgebiet Radiologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.